News
OCS-Sparing Effect of Dupilumab for Severe Asthma Maintained
Oral corticosteroid dosage reduction sustained in open-label extension study of dupilumab
Your search for oral corticosteroids returned 8 results
News
Treatment Needs Often Unmet for Generalized Pustular Psoriasis
Patients with flares more likely to have inpatient, emergency department visits
Drugs in the Pipeline
Efzofitimod Gets Fast Track Status for Pulmonary Sarcoidosis
Efzofitimod is a potential first-in-class selective modulator of neuropilin-2 that is designed to downregulate innate and adaptive immune responses in inflammatory disease states.
News
FDA Approval Allows for Use of Dupixent Prefilled Pens in Younger Patients
Dupixent single-dose prefilled pens feature a hidden needle and single-press auto-injection.
CHEST 2022, News
Switching or Stopping Biologic Therapy in Severe Asthma Yields Worse Outcomes
The CLEAR study compared clinical outcomes and health resource usage in patients with severe asthma who continued, switched, or stopped their biologic treatment.
News
Rinvoq Approved for Moderately to Severely Active Ulcerative Colitis
The approval was based on data from two phase 3 induction studies and one phase 3 maintenance study.
News
Tacrolimus May Be an Alternative for First-Line Lupus Nephritis Therapy
In a study, the calcineurin inhibitor tacrolimus proved to be noninferior to intravenous cyclophosphamide.
Drugs in the Pipeline
Vamorolone Under Review for Duchenne Muscular Dystrophy
Vamorolone is a first-in-class dissociative steroidal drug that retains the anti-inflammatory activity of corticosteroids but with a novel mechanism of action.
